FDA Approved: TEMOZOLOMIDE — Supplemental Application (CivicaScript LLC)

View source ↗

Summary

FDA approved CivicaScript LLC's supplemental application for temozolomide, a generic version of the chemotherapy drug Temozolomide (ANDA 207658).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Glioblastoma Multiforme

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

SUPPL AP for TEMOZOLOMIDE (TEMOZOLOMIDE)